We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
ABI Unveils TaqMan® Low Density Array Gene Signature Panels
Product News

ABI Unveils TaqMan® Low Density Array Gene Signature Panels

ABI Unveils TaqMan® Low Density Array Gene Signature Panels
Product News

ABI Unveils TaqMan® Low Density Array Gene Signature Panels


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "ABI Unveils TaqMan® Low Density Array Gene Signature Panels"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Applied Biosystems has introduced four Gene Signature Panels as part of its TaqMan® Low Density Array (TLDA) product line for real-time PCR applications.

The arrays include the Human G Protein-Coupled Receptors (GPCR) Panel, Human Protein Kinase Panel, Mouse Immune Panel, and Human Endogenous Controls Panel.

The Applied Biosystems TaqMan Low Density Arrays are 384-well micro fluidic cards designed for analysing gene expression patterns in many samples across a defined set of gene targets.

ABI claims that, the arrays use gold standard TaqMan chemistry for quantitative gene expression and combine the accuracy, sensitivity and high reproducibility of real-time PCR with the convenience of pre-configured panels for target screening and disease association research.

The Gene Signature Panels are available off-the-shelf and in smaller quantities, and Applied Biosystems also offers custom TaqMan Low Density Arrays, allowing researchers to design their own assay panels by choosing genes of interest from 40,000 inventoried TaqMan Gene Expression Assays.

Advertisement